Published in Cardiovascular Week, April 25th, 2005
"L-Arginine is a substrate for nitric oxide (NO) synthesis and produces pulmonary vasodilatory effects in patients with pulmonary hypertension and in hypoxic animals," according to scientists in Brazil, who "hypothesized that L-arginine would attenuate the increase in oxidative stress and the pulmonary hypertension" associated with APE.
"Using an isolated lung perfusion rat model of APE," D.C. Souza-Costa and colleagues at the University of Sao Paulo "examined whether L-arginine (0, 0.1, 0.5, 3, and 10 mmol/L) attenuates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.